Q3SX13 (IPKA_BOVIN) Bos taurus (Bovine)
cAMP-dependent protein kinase inhibitor alpha UniProtKBInterProSTRINGInteractive Modelling
76 aa; Sequence (Fasta) ;
34 identical sequences
Available Structures
22 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| PKA-S6K1 Chimera with compound 21e (CCT239066) bound |
Heteromer P00517; | 100 | 1×VUP; 3×MOH; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; | 100 | 1×MPD; 1×QWI; 1×GOL; 1×DMS; | |||
| PKA-S6K1 Chimera with compound 21a (CCT196539) bound |
Heteromer P00517; | 100 | 1×Z21; 1×MPD; | |||
| Structure of bovine PKA bound to (R)-N-(4-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl)-2-amino-4-methylpe… |
Heteromer P00517; | 100 | 1×ZWG; | |||
| PKA-S6K1 Chimera with compound 15e (CCT147581) bound |
Heteromer P00517; | 100 | 1×ZO9; 1×MOH; | |||
| Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors |
Heteromer P00517; | 100 | 1×G98; | |||
| CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH inhibitor. |
Heteromer P00517; | 100 | 1×0RW; | |||
| PKA structures of AKT, indazole-pyridine inhibitors |
Heteromer P00517; | 100 | 1×SS3; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; | 100 | 1×SS4; | |||
| PKA three fold mutant model of Rho-kinase with Y-27632 |
Heteromer P00517; | 100 | 1×Y27; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; | 100 | 1×L20; | |||
| PKA structures of indazole-pyridine series of AKT inhibitors |
Heteromer P00517; | 100 | 1×SS5; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; | 100 | 1×9CY; | |||
| PKA-S6K1 Chimera Apo |
Heteromer P00517; | 100 | ||||
| PKA-S6K1 Chimera with Staurosporine bound |
Heteromer P00517; | 100 | 1×STU; 1×GOL; 1×MG8; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; | 100 | 1×9D4; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; | 100 | 1×15I; 2×GOL; 1×MPD; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; | 100 | 1×SIJ; 4×GOL; 2×MOH; | |||
| The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors |
Heteromer P00517; | 100 | 1×QNI; 7×MOH; 4×GOL; | |||
| PKA-S6K1 Chimera with compound 1 (NU1085) bound |
Heteromer P00517; | 100 | 1×NU3; 1×MPD; | |||
| Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors |
Heteromer P00517; | 100 | 1×G96; | |||
| Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … |
Heteromer P00517; | 100 | 1×9D1; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3wyg.1.C | monomer | 0.65 | 97.37 | |||